Navigation Links
Miscarriage Treatment Won't Harm Future Fertility: Study
Date:10/9/2009

Most women give birth within five years, researchers find

FRIDAY, Oct. 9 (HealthDay News) -- The current treatments for women who've had an early miscarriage don't affect their long-term fertility, new research shows.

About 15 percent of pregnancies end in miscarriage in the first trimester. For decades, standard treatment was surgery to remove tissue remaining in the uterus, but now many women are offered expectant (watch and wait) and medical treatment as well, according to background information in the study.

Previous research found that infection rates are about the same for all three methods, but little information was available about their long-term effects on fertility.

The new British study, published online Oct. 9 in the BMJ, included 762 women who had received surgical, medical or expectant management for an early miscarriage. Asked about subsequent pregnancies and live births, 83.6 percent of the women reported a subsequent pregnancy and 82 percent had had a live birth.

Live birth within five years of miscarriage was reported by 78.7 percent of those who received medical treatment, 79 percent who received expectant management, and 81.7 percent of those who had had surgery, the researchers found.

Older women and those who experienced three or more miscarriages were much less likely to have a subsequent live birth, the study authors noted.

"Women can be reassured that long-term fertility concerns need not affect their choice of miscarriage management method," the researchers concluded.

More information

The U.S. National Institute of Child Health and Human Development has more about miscarriage.



-- Robert Preidt



SOURCE: BMJ, news release, Oct. 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Miscarriage myths persist despite prevalence of medical information
2. Miscarriage of Justice: A Statement by Judie Brown of the American Life League
3. Prior Miscarriage Raises Risk for Low-Birthweight Infant
4. Kaiser Permanente study shows link between caffeine and miscarriage
5. New Kaiser Permanente study fortifies caffeines link to miscarriage
6. Once Again, Caffeine Linked to Miscarriage
7. Leicester medical team announces predictor for pregnant women who may have miscarriages
8. Women Veterinarians Face Higher Miscarriage Risk
9. Larger hospital units have lower miscarriage rates after invasive pregnancy tests
10. New treatment effective in counteracting cocaine-induced symptoms
11. New treatment boosts muscle function in myasthenia gravis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... and check-in, a cloud-based self-service technology that runs on the Posiflex XT-series of ... No. 1076 during HIMSS17 in Orlando, Florida. The terminal provider Posiflex ...
(Date:2/20/2017)... ... February 20, 2017 , ... Best Doctors® and IBM ... benefit for companies that want to help members of their workforce battling cancer. ... access to Watson’s suite of oncology offerings for insights on cancer treatment options, ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and Center for ... joint event at Chuck E. Cheese’s locations throughout New England, New York and New ... opportunity to experience the fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. ...
(Date:2/19/2017)... Van Wert, OH (PRWEB) , ... February 19, 2017 , ... ... known as The JEMS Conference & Exposition, the event will take place February 23-25, ... Utah. Braun Industries will be in Booth #909 with three new ambulances ...
(Date:2/18/2017)... Church, VA (PRWEB) , ... ... ... Culture of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 2017 According to a new market research ... Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User ... MarketsandMarkets, the market is expected to reach USD 330.6 Million by ... 3.7% from 2016 to 2021. Continue ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
Breaking Medicine Technology: